SG Americas Securities LLC Sells 113,213 Shares of Perrigo Company plc $PRGO

SG Americas Securities LLC decreased its stake in shares of Perrigo Company plc (NYSE:PRGO) by 84.2% during the 1st quarter, Holdings Channel reports. The institutional investor owned 21,220 shares of the company’s stock after selling 113,213 shares during the period. SG Americas Securities LLC’s holdings in Perrigo were worth $228,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of PRGO. Price T Rowe Associates Inc. MD raised its position in Perrigo by 3.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 17,574,227 shares of the company’s stock valued at $244,634,000 after buying an additional 653,925 shares during the last quarter. Vanguard Group Inc. lifted its stake in Perrigo by 7.9% during the 4th quarter. Vanguard Group Inc. now owns 14,983,369 shares of the company’s stock valued at $208,568,000 after acquiring an additional 1,101,154 shares in the last quarter. Fuller & Thaler Asset Management Inc. boosted its holdings in Perrigo by 291.9% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 7,824,759 shares of the company’s stock worth $108,921,000 after acquiring an additional 5,828,076 shares during the last quarter. State Street Corp grew its stake in shares of Perrigo by 9.5% in the 2nd quarter. State Street Corp now owns 7,340,323 shares of the company’s stock worth $196,134,000 after acquiring an additional 637,678 shares in the last quarter. Finally, Thompson Siegel & Walmsley LLC grew its stake in shares of Perrigo by 28.4% in the 4th quarter. Thompson Siegel & Walmsley LLC now owns 4,658,601 shares of the company’s stock worth $64,848,000 after acquiring an additional 1,029,770 shares in the last quarter. Institutional investors own 95.91% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on PRGO shares. Zacks Research raised shares of Perrigo from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings raised shares of Perrigo from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, June 15th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $19.33.

Perrigo Stock Performance

PRGO traded down $0.21 during midday trading on Friday, reaching $10.20. The company had a trading volume of 3,394,096 shares, compared to its average volume of 3,964,873. Perrigo Company plc has a 12-month low of $9.23 and a 12-month high of $28.43. The business has a 50-day moving average price of $10.80 and a two-hundred day moving average price of $12.03. The stock has a market cap of $1.41 billion, a PE ratio of -0.78, a P/E/G ratio of 1.21 and a beta of 0.51. The company has a debt-to-equity ratio of 1.45, a quick ratio of 1.59 and a current ratio of 2.72.

Perrigo (NYSE:PRGO) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.04. Perrigo had a negative net margin of 43.50% and a positive return on equity of 9.96%. The company had revenue of $841.80 million during the quarter, compared to analyst estimates of $1.04 billion. During the same quarter last year, the business posted $0.60 EPS. Perrigo’s quarterly revenue was down 7.2% compared to the same quarter last year. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, sell-side analysts expect that Perrigo Company plc will post 2.11 earnings per share for the current fiscal year.

Perrigo Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Friday, May 29th were issued a $0.29 dividend. The ex-dividend date of this dividend was Friday, May 29th. This represents a $1.16 annualized dividend and a yield of 11.4%. Perrigo’s dividend payout ratio (DPR) is -8.85%.

About Perrigo

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.